PUBLICATIONS · 33979489
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2021 May 13
- First author
- Tiacci E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2021 Jul;18(7):399. doi: 10.1038/s41571-021-00526-9.
- note
- Source null
- related pmid
- 34031574
- relationship
- Comment in
Authors and identifiers
- name
- Tiacci E
- type
- Author
- name
- De Carolis L
- type
- Author
- name
- Simonetti E
- type
- Author
- name
- Capponi M
- type
- Author
- name
- Ambrosetti A
- type
- Author
- name
- Lucia E
- type
- Author
- name
- Antolino A
- type
- Author
- name
- Pulsoni A
- type
- Author
- name
- Ferrari S
- type
- Author
- name
- Zinzani PL
- type
- Author
- name
- Ascani S
- type
- Author
- name
- Perriello VM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Tiacci E
- type
- Author
- name
- De Carolis L
- type
- Author
- name
- Simonetti E
- type
- Author
- name
- Capponi M
- type
- Author
- name
- Ambrosetti A
- type
- Author
- name
- Lucia E
- type
- Author
- name
- Antolino A
- type
- Author
- name
- Pulsoni A
- type
- Author
- name
- Ferrari S
- type
- Author
- name
- Zinzani PL
- type
- Author
- name
- Ascani S
- type
- Author
- name
- Perriello VM
- type
- Author
- bibliography ids
- nci-bib-444cef8579f69dc4c9bb9e7b
- book metadata
- content sha256
- 34384fcb42ce8ad6a8f6f3d32251e6f705fc3d55c2c5aaaf404e1ba5897966ae
- document type
- citation
- dois
- 10.1056/NEJMoa2031298
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33979489
- immutable id
- pubmed:33979489@34384fcb42ce8ad6a8f6f3d32251e6f705fc3d55c2c5aaaf404e1ba5897966ae
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 19
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 1810-1823
- volume
- 384
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2021 Jul;18(7):399. doi: 10.1038/s41571-021-00526-9.
- note
- Source null
- related pmid
- 34031574
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 33979489
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- 4dbe5d13498892eae9786db371d4c00af14be8a89b3e6323479dc4060e4547e5
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 May 13
- precision
- day
- year
- 2021
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
Preserved source evidence · Not medical advice
Triangle